Brief: Spago Nanomedical: Tumorad Patent Granted In Europe

Spago Nanomedical AB (publ)

04/12/2018 13:21

Dec 4 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.TE :
    * TUMORAD® PATENT GRANTED IN EUROPE
    * PATENT IS VALID UNTIL 2035

Source text for Eikon:  ID:nWkr7jLZzZ 
Further company coverage:  SPAGO.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))